The Transfer-Forward study is ongoing so we need to anticipate the study being full or interim effects grow to be out there just before We all know if or how nicely molnupiravir prevents COVID-19. As a result molnupiravir is just not licensed to forestall COVID-19. Some observational studies have evaluated https://imatinibmesylate00987.canariblogs.com/5-simple-statements-about-zd-0892-explained-43359875